- Advertise
- Contact Us
- Contribute
- Editorial Info
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Personal Information
- About Us
© 2021 MJH Life Sciences™ and Endocrinology Network. All rights reserved.
Latest Conference Articles
Expanded Doses of Dulaglutide Safe, Efficacious Regardless of Baseline HbA1c
March 25, 2021
Juan Frias, MD, breaks down results of a post-hoc analysis of the AWARD-11 study examining expanded doses of dulaglutide according to baseline HbA1c levels.
Study Calls for Increased Screening of Primary Aldosteronism
March 25, 2021
An analysis presented at ENDO 2021 suggests less than 5% of patients at high risk for primary aldosteronism undergo screening and most screenings occur after the onset of symptoms.
COVID-19 Could Cause Atypical Thyroid Inflammation
March 24, 2021
A study from ENDO 2021 indicates moderate-to-severe COVID-19 infections are associated with atypical thyroid inflammation.
Alternating Doses of Denosumab Therapy Equally as Effective, Real-World Study Finds
March 24, 2021
Switching from 60 mg to 30 mg denosumab every 6 months could be an option for patients who have completed long-term denosumab therapy, according to the results of a new study from McMaster University.
Once-Weekly Basal Insulin Fc Shows Promise in Phase 2 Trial
March 23, 2021
Learn more about once-weekly basal insulin Fc from Eli Lilly and Company in this interview with the lead investigator from their phase 2 trial, which was presented at ENDO 2021.
SGLT2 Inhibitor Use is Safe, Efficacious in Kidney Transplant Patients with Diabetes, Study Finds
March 22, 2021
A literature review of studies assessing SGLT2 inhibitor use in kidney transplant patients with diabetes suggests use did not impact graft function and was associated with improvements in glucose control and body weight.
Black Women with PCOS at Greater Cardiometabolic Risk than White Counterparts
March 22, 2021
A meta-analysis of nearly a dozen studies presented at ENDO 2021 suggests Black women with PCOS were at an increased cardiometabolic risk, despite having comparable fasting glucose and lower triglyceride levels.
Thyroid Combination Therapy Preferred Over Levothyroxine for Some Hypothyroidism Patients
March 21, 2021
A randomized, 3-arm study is giving further insight into the effects of levothyroxine monotherapy compared against a thyroid combination therapy and desiccated thyroid extract for management of hypothyroidism, particularly in patients with Thr92AlaD2 polymorphism.
Many Endocrine Providers, Patients Open to Continuing Telehealth Practices
March 21, 2021
An analysis of patients and providers from endocrine clinics suggests many patients and providers were open to continuing with telehealth practices after the pandemic and many saw little to no limitations with the new practices.
Transgender Youth at Increased Risk of Dyslipidemia, Other Cardiometabolic Conditions
March 20, 2021
An analysis of 4k transgender youth and 16k propensity-matched controls is providing insight into the increased risk of conditions adversely impacting the cardiometabolic health of these patients.